EDASTAR INJECTION contains Edaravone which belongs to group of medicines called Antioxidants. EDASTAR INJECTION is used to treat amyotrophic lateral sclerosis (nervous system disease that weakens muscles and impacts physical function) in affected individuals.
EDASTAR INJECTION is not recommended for use if you are allergic to Edaravone.
Before receiving EDASTAR INJECTION, inform your doctor if you have lung problems (such as asthma), kidney problems (such as impaired renal insufficiency), and/or liver problems (such as mild/moderate/severe hepatic insufficiency).
EDASTAR INJECTION should be used with caution in pregnant and breastfeeding women only if it is clearly necessary since there is no adequate data to determine safety and efficacy of the medicine.
EDASTAR INJECTION is not recommended for use in children and adolescents (below 18 years) as there is no adequate data to determine the safety and efficacy of the medicine in children. It is advised to be used with caution in elderly patients (aged 65 years/above) after consulting the doctor.
The most common side effects of receiving EDASTAR INJECTION are confusion, gait disturbance, headache, dermatitis, eczema, and/or tinea infection (fungal infection of skin). Consult and inform your doctor if any of these symptoms worsen.
EDASTAR INJECTION works by relieving the effects of oxidative stress (condition that occurs due to imbalance of free radicals and antioxidants in the body during ageing process) which results in delayed nerve damage associated with the symptoms of amyotrophic lateral sclerosis condition thus preserving the motor function and treating the associated symptoms of the condition in affected individuals.
EDASTAR INJECTION will be given to you only by a doctor or a nurse into a vein as an intravenous infusion. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition.
Stop receiving EDASTAR INJECTION and contact your doctor immediately if you have:
Headache:
If EDASTAR INJECTION causes headache, then take rest and drink plenty of fluids. Try to avoid drinking alcohol. Ask your doctor to recommend a painkiller. Headaches should usually go away after the first week of taking EDASTAR INJECTION. If it lasts more than a week or severe, inform your doctor.
EDASTAR INJECTION should be used with caution during pregnancy and in women planning for pregnancy only if it clearly necessary since there is no adequate data to determine safety and efficacy of the medicine. Consult your doctor before receiving the medicine.
EDASTAR INJECTION should be used with caution in breastfeeding women only if it is clearly necessary as there is no data to determine its safety and efficacy. Consult your doctor before receiving the medicine.
EDASTAR INJECTION should be used with caution in patients with kidney problems such as renal insufficiency. Consult your doctor before receiving the medicine.
EDASTAR INJECTION should be used with caution in patients with liver problems such as mild/moderate/severe hepatic insufficiency. Consult your doctor before receiving the medicine.
Do not receive EDASTAR INJECTION if you are allergic to edaravone, and/or any other ingredients of this medicine. It should be used with caution in patients allergic to sulfites. Consult and inform your doctor before receiving the medicine.
EDASTAR INJECTION should be used with caution in patients with lung problems such as asthma. Consult your doctor before receiving the medicine.
Use in Pediatrics:
EDASTAR INJECTION is not recommended for use in children and adolescents (below 18 years) as there is no adequate data to determine the safety and efficacy of the medicine in children. Consult your doctor before administering the medicine to the child.
Use in Geriatrics:
EDASTAR INJECTION should be received with caution in elderly patients (aged above 65 years). Consult and inform your doctor before receiving the medicine.
A. Drug-Drug interactions:
Before taking EDASTAR INJECTION, inform your doctor if you are taking:
Over dosage:
EDASTAR INJECTION will be administered to you only by a doctor or a nurse in a hospital, and so it is unlikely to receive an overdose. However, consult your doctor or nurse if you experience any unusual symptoms.
Drug | : | Edaravone |
Pharmacological Category | : | Antioxidants |
Therapeutic Indication | : | Amyotrophic lateral sclerosis |
Dosage Forms | : | Injection |
What are the uses of EDASTAR INJECTION?
EDASTAR INJECTION is used to treat amyotrophic lateral sclerosis in affected individuals which is a progressive neuro muscular disease that weakens muscles and impacts physical function, generally characterized by symptoms such as difficulty while walking, tripping & falling, weakness in legs/feet/ankles, slurred speech, and/or trouble swallowing.
What are the side effects of EDASTAR INJECTION?
The most common side effects of receiving EDASTAR INJECTION are confusion, gait disturbance, headache, dermatitis, eczema, and/or tinea infection (fungal infection of skin). Contact your doctor if any of these symptoms worsen.
Is EDASTAR INJECTION safe to be used in pregnant and breastfeeding women?
Yes, EDASTAR INJECTION can be used but with caution during pregnancy only if it is clearly necessary. It is also advised to be used with caution in breast feeding only if needed since it is unknown whether the medicine may get excreted through breastfed milk. Consult your doctor before receiving the medicine.
How EDASTAR INJECTION works?
EDASTAR INJECTION works by relieving the effects of oxidative stress (condition that occurs due to imbalance of free radicals and antioxidants in the body during ageing process) which results in delayed nerve damage associated with the symptoms of amyotrophic lateral sclerosis condition thus preserving the motor function and treating the associated symptoms of the condition in affected individuals.
How much dose can EDASTAR INJECTION be received in a day?
EDASTAR INJECTION is generally given to you only by a doctor or a nurse into a vein as an intravenous infusion. Your doctor will decide the correct dose and duration depending on your age, body weight and disease condition.
1. Patrick A. Lewis, Jennifer E. Spillane. The motor neuron diseases and amyotrophic lateral sclerosis. The Molecular and Clinical Pathology of Neurodegenerative Disease. Edition 2018. Page: 178.
2. R Bhandari, A Kuhad. Edaravone: a new hope for deadly amyotrophic lateral sclerosis. NIH National Library of medicine. National Center for Biotechnology Information. PubMed.gov. [Revised in June 2018] [Accessed on 19th May 2022] https://pubmed.ncbi.nlm.nih.gov/29998226/
3. Martin Paspe Cruz. Edaravone (Radicava). NIH National Library of medicine. National Center for Biotechnology Information. PMC PubMed Central. January 2018. [Accessed on 19th May 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5737249/
4. Mitsubishi Tanabe Pharma Corporation. Drug and Health Product Register (HRES). [Revised in October 2018] [Accessed on 19th May 2022] https://pdf.hres.ca/dpd_pm/00047612.PDF
5. Taj Pharma. Edaravone Injection. [Accessed on 19th May 2022] https://tajpharma.in/portfolio-item/edaravone-injection-1-5mg/
Written By Dr. K .AZEEM HUSSAIN, B.D.S
Last updated on 06 Dec 2022 | 03:54 PM(IST)
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.